Product Name : Sunitinib Malate
CAS : 341031-54-7
Molecular Formula : C22H27FN4O2.C4H6O5
Molecular Weight : 532.56
Pharmaceutical Grade : IH
Therapeutic Category : Antineoplastic; Tyrosine Kinase Inhibitors
Global calcium is one of the leading manufacturers and exporters of Sunitinib CAS No.341031-54-7, API, (Active Pharmaceutical Ingredient). We support the customers with exhaustive documentation. As a USDMF & EU-GMP certified global company and an established hallmark for pharmaceutical standards, global calcium has stood the test of time since its inception in 1979.
As manufacturer of Sunitinib we hereby state the following facts about the drug:
Sunitinib is indicated for the:
treatment of meningioma, which is associated with neurofibromatosis.
Mechanism of action
Sunitinib inhibits cellular signalling by targeting multiple receptor tyrosine kinases (RTKs).
These include all receptors for platelet-derived growth factor (PDGF-Rs) and vascular endothelial growth factor receptors (VEGFRs), which play a role in both tumor angiogenesis and tumor cell proliferation. The simultaneous inhibition of these targets therefore reduces tumor vascularization and triggers cancer cell apoptosis and thus results in tumor shrinkage.
Global calcium is a leading manufacturer of this drug. We manufacture this pharmaceutical drug and make it available to domestic and overseas market.
